Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,714 USD | -0,06% | -12,10% | -45,06% |
Vakgebied
Aantal werknemers: 11
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 79 | 01-09-15 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 19-07-23 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-15 |
John Neylan
CTO | Chief Tech/Sci/R&D Officer | 70 | 08-11-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 01-06-16 |
Founder | 79 | 01-09-15 | |
Director/Board Member | 61 | 05-07-23 | |
Samir R. Patel
CEO | Chief Executive Officer | 55 | 29/11 |
Director/Board Member | 70 | 23-01-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 13 234 315 298 | 13 101 972 145 ( 99,00 %) | 0 | 99,00 % |
Bedrijfsgegevens
Akari Therapeutics Plc
22 Boston Wharf Road 7th Floor
02210, Boston
+929 274 7510
http://www.akaritx.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-45,06% | 13,58 mln. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,17% | 21,96 mld. | |
-8,35% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. | |
+77,64% | 8,87 mld. |
- Beurs
- Aandelen
- Koers AKTX
- Onderneming Akari Therapeutics, Plc